NCT04544514

Brief Summary

Lung ultrasonography (LUS) is fast and easy technique. it also has high reliability, so it has started to be used more in evaluating respiratory distress in the neonatal period. The most important feature of LUS is being radiation-free. Three LUS findings that show respiratory distress syndrome were described. They were white lung appearance, lack of preserved areas and loss of pleural integrity. The sensitivity of these findings was found to be 98-100% and the specificity 92-100%. A few studies have shown that surfactant need can be determined by LUS. It was observed that lung findings were more severe in LUS performed in the early period because of non-completed fetal lung fluid clearence, but the findings could be improved during follow-up. Therefore, it is not known when the earliest time of LUS shows the actual clinical condition and course of the patient. This study was planned to find the most reliable and earliest US time. Evaluation with LUS was done at 30 minutes and repeated at 1, 2, 4 and 6 hours of life. The LUS findings would be compared with x-ray findings and the correlation of surfactant need with LUS findings would also be investigated.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 3, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 10, 2020

Completed
Last Updated

September 11, 2020

Status Verified

September 1, 2020

Enrollment Period

3 years

First QC Date

September 3, 2020

Last Update Submit

September 9, 2020

Conditions

Outcome Measures

Primary Outcomes (5)

  • lung ultrasound at 30 minutes

    lung ultrasound findings

    30 minutes

  • lung ultrasound at 1 hour

    lung ultrasound findings

    1 hour

  • lung ultrasound at 2 hour

    lung ultrasound findings

    2 hour

  • lung ultrasound at 4 hour

    lung ultrasound findings

    4 hour

  • lung ultrasound at 6 hour

    lung ultrasound findings

    6 hour

Interventions

lung ultrasoundDIAGNOSTIC_TEST

LUS was performed within first 20 to 30 minutes and repeated at 1, 2, 4 and 6 hours.

Eligibility Criteria

Age30 Minutes - 6 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

extreme preterm babies with a gestational age 32 weeks or less were admitted to NICU. Only babies who were treated with CPAP because of clinical signs of respiratory distress were enrolled the study.

You may qualify if:

  • preterm babies with a gestational age 32 weeks or less
  • babies treated with CPAP

You may not qualify if:

  • If a baby was intubated in delivery room because of the responsiveness to face-mask ventilation, he/she was excluded.
  • congenital heart diseases
  • complex congenital malformations
  • chromosomal abnormalities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kayki G, Yigit S, Tandircioglu UA, Celik HT, Yurdakok M. Lung ultrasound (LUS) and surfactant treatment: looking for the best predictive moment. J Perinatol. 2021 Jul;41(7):1669-1674. doi: 10.1038/s41372-021-01039-0. Epub 2021 Mar 23.

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

September 3, 2020

First Posted

September 10, 2020

Study Start

January 1, 2017

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

September 11, 2020

Record last verified: 2020-09